⌕
Prestige Consumer Healthcare · PBH · NYSE
Tenet 52 · Mixed
Compare
$48.00+3.92%At closeTenet 52 · Mixed
$48.00+1.81 (+3.92%)
At close: Nov 16, 2026, 4:00 PM ET· NYSE · USD

Prestige Consumer Healthcare (PBH) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue fell 4.3% in FY26, net margin 17.5%, and free cash flow (~$246.4M) tracks net income. Earnings are cash, not paper.
The four lines that matter · FY22–FY26
Revenue ($M)▼4.3%
1,088.7
FY22→FY26CAGR +0.0%/yr
Net income ($M)▼11.3%
190.3
one-off year: see footnoteCAGR −1.9%/yr
Free cash flow ($M)▲1.3%
246.4
FY22→FY26CAGR −0.4%/yr
Diluted EPS▼8.9%
3.91
buyback-liftedCAGR −0.8%/yr
What the receipts whisper · what a headline number hides
Share count
−4.2%

50.8mn → 48.7mn diluted shares since FY22. Part of EPS growth is the shrinking denominator. Watch net income too.

Capex
$11.2M

+35.9% YoY in FY26 · 1.0% of revenue.

What the income statement says · FY22–FY26
Where every revenue dollar goes · FY26 ($M)1088.7Revenue−493.1COGS595.6Gross profit−116.4SG&A309.4Op income−119.1Tax & other190.3Net income

17¢ of every revenue dollar becomes profit. The biggest cost lever is COGS.

Margin trend · direction beats level Gross Operating Net
604530150%sector median net margin ~4%FY22FY26

Over this window: gross 57.1% → 54.7%. Net margin 17.5% is more than double the sector median.

The receipt · income statement · FY22–FY26 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
Line itemTTM †FY26FY25FY24FY23FY22YoYCAGR 22→26
Revenue & profitability
Revenue
1,167.11,088.71,137.81,125.41,127.71,086.8▼4.3%+0.0%
Cost of revenue
554.7493.1503.3500.9502.4466.2▼2.0%+1.4%
Gross profit
612.4595.6634.5624.4625.3620.6▼6.1%−1.0%
Selling, general & admin
134.2116.4108.2106.2107.4107.5▲7.6%+2.0%
Total operating expenses
321.2286.2297.7282.0647.7290.7▼3.9%−0.4%
Operating incomefeeds ROC rank
291.2309.4336.8342.4−22.4329.9▼8.1%−1.6%
Other income, net
−78.6−51.9−52.6−66.4−71.5−67.5——
Pretax income
212.6257.5284.2276.0−93.9262.5▼9.4%−0.5%
Income tax
57.567.269.666.7−11.657.1▼3.4%+4.2%
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings
155.1190.3214.6209.3−82.3205.4▼11.3%−1.9%
Per share
Diluted EPSbuyback-sensitive
3.243.914.294.17−1.654.04▼8.9%−0.8%
Diluted shares (mn)
47.5948.7250.0850.1849.8950.84▼2.7%−1.1%
Margins
Gross margin30th pct in Healthcare
52.5%54.7%55.8%55.5%55.4%57.1%▼1.1pp−2.4pp
Operating margin
25.0%28.4%29.6%30.4%−2.0%30.4%▼1.2pp−1.9pp
Net margin74th pct in Healthcare
13.3%17.5%18.9%18.6%−7.3%18.9%▼1.4pp−1.4pp
† TTM = trailing four quarters through 2026-09-30.FY23 effective tax rate was 12% vs a 24% norm for this window, likely a one-time item; see the filing.
FY10 – FY21 · 12 more years
Unlock the full history →
5 more years of statements and CSV export are on Premium, and 12 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-05-14 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was Prestige Consumer Healthcare's revenue last fiscal year?

Prestige Consumer Healthcare reported revenue of $1,088.7M in fiscal 2026, down 4.3% from fiscal 2025.

What was Prestige Consumer Healthcare's net income?

Prestige Consumer Healthcare reported net income of $190.3M in fiscal 2026, a net margin of 17.5%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.